Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Clinical trial NCT06679270 · RECRUITING
Trial details
- NCT number
- NCT06679270
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-14
- Primary completion
- 2028-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.